|
2023
|
Invention
|
Novel kinase modulators.
The present invention provides PI3K protein kinase modulators, methods ... |
|
|
Invention
|
A dual selective pi3k delta and gamma inhibitors and/or a salt-inducible kinase 3 inhibitor for t... |
|
|
Invention
|
Pol theta inhibitors. The present invention relates to compounds of formula (I), that possess DNA... |
|
|
Invention
|
(4-piperazin-1yl)-4-alkyl-phthalazin-1(2h)-one compounds as parp7 inhibitors. The present inventi... |
|
2022
|
Invention
|
Inhibitors of poly(adp-ribose) polymerase.
The present invention relates to Poly(ADP-ribose) pol... |
|
|
Invention
|
Inhibitors of poly(adp-ribose) polymerase. The present invention relates to Poly(ADP-ribose) poly... |
|
|
Invention
|
Cdk inhibitors. The present invention provides compounds of formula (I) and pharmaceutically acce... |
|
2021
|
Invention
|
Phthalazinone derivatives useful as parp inhibitors. The present invention provides compounds of ... |
|
|
Invention
|
Purine derivatives as sik-3 inhibitors.
The present invention relates to novel inhibitors of sal... |
|
|
Invention
|
Purine derivatives as sik-3 inhibitors. The present invention relates to purine derivatives as in... |
|
|
Invention
|
Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitors.
The present invention p... |
|
|
Invention
|
Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitors. The present invention pr... |
|
2020
|
Invention
|
Forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations.
The present in... |
|
|
Invention
|
Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemia.
The prese... |
|
|
Invention
|
Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemia. The presen... |
|
|
Invention
|
Method of treatment and compositions comprising a dual p13k delta-gamma kinase inhibitor and a co... |
|
|
Invention
|
Dual selective pi3 delta and gamma kinase inhibitors. The present invention relates to dual delta... |
|
|
Invention
|
Novel glutaminase inhibitors.
The present disclosure provides compounds of formula (I) to (III) ... |
|
|
Invention
|
Selective dual inhibitors of pi3 delta and gamma protein kinases.
The present invention relates ... |
|
|
Invention
|
Selective pi3k delta inhibitors. The present invention relates to selective inhibitors of PI3K de... |
|
2019
|
Invention
|
Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereof.
The pr... |
|
|
Invention
|
Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereof. The pre... |
|
|
Invention
|
Kinase modulators. The present invention provides PI3K protein kinase modulators of Formula (I)
... |
|
|
Invention
|
Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma k... |
|
|
Invention
|
Forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations. The present inv... |
|
|
Invention
|
Intermediates useful in the synthesis of compounds as modulators of protein kinases. The present ... |
|
|
Invention
|
Modulators of calcium release-activated calcium channel. Disclosed are novel calcium release-acti... |
|
2018
|
Invention
|
Composition and method for treating peripheral t-cell lymphoma and cutaneous t-cell lymphoma.
Th... |
|
|
Invention
|
Calcium release-activated calcium channel modulators for treating hematological and solid cancers... |
|
|
Invention
|
Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-... |
|
|
Invention
|
3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted-3h-[1,2,3]triazolo[4,5-b] pyrid... |
|
2017
|
Invention
|
Glutaminase inhibitors. The present disclosure provides compounds of formula (I) to (III) as glut... |
|
|
Invention
|
Substituted chromenones as modulators of protein kinases. The present invention provides PI3K pro... |
|
|
Invention
|
Dual selective p13 delta and gamma kinase inhibitors. The present invention relates to dual delta... |
|
|
Invention
|
Selective dual inhibitors of pi3 delta and gamma protein kinases. The present invention relates t... |
|
2015
|
Invention
|
Method of treatment and compositions comprising a dual pi3k delta-gamma kinase inhibitor and a co... |
